Cresco Labs (CRLBF) Share-based Compensation (2019 - 2026)
Cresco Labs (CRLBF) posted Share-based Compensation of $5.3 million for Q1 2026, up 169.33% on a QoQ basis from -$7.6 million in Q4 2025, and up 92.99% year-over-year from $2.7 million in Q1 2025.
Cresco Labs (CRLBF) Share-based Compensation (2019 - 2026) Analysis & Trends
Cresco Labs' Share-based Compensation history runs 8 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- Quarterly Share-based Compensation rose 92.99% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 80.05% YoY) and the FY2024 annual result came in at $14.2 million, down 13.4% from the prior year.
- Share-based Compensation was $5.3 million for Q1 2026 at Cresco Labs, up from -$7.6 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.5 million in Q1 2022 and bottomed at -$7.6 million in Q4 2025.
- A 5-year average of $3.5 million and a median of $3.5 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2025 — Share-based Compensation plunged 304.59% — and 2026, when it soared 92.99%.
- Cresco Labs' Share-based Compensation stood at $5.3 million in 2022, then slumped by 42.76% to $3.0 million in 2023, then grew by 22.8% to $3.7 million in 2024, then plunged by 304.59% to -$7.6 million in 2025, then jumped by 169.33% to $5.3 million in 2026.
- Business Quant data shows CRLBF's Share-based Compensation at $5.3 million in Q1 2026, -$7.6 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 5.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.26 Mn |
| Mar 31, 2026 | 5.26 Mn |
| Dec 31, 2025 | -7.58 Mn |
| Dec 31, 2025 | -7.58 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.55 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Dec 31, 2023 | 3.02 Mn |